Beyond recurrence: redefining atrial fibrillation burden as a prognostic and therapeutic endpoint

Andrea Ballatore1,2, Carola Griffith Brookles1,2, Mark O'Neill3,4

  • 1Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza Hospital, Turin, Italy.

PubMed

Insights

Atrial fibrillation (AF) burden, the percentage of time spent in arrhythmia, offers a more accurate measure of treatment success than traditional methods. Further research is needed to standardize its definition and application in clinical practice.

Area of Science:

  • Cardiology
  • Medical Technology

Background:

  • Traditional atrial fibrillation (AF) classification by episode duration and binary recurrence assessment (e.g., >30s) have limitations.
  • Current methods may not accurately reflect time in arrhythmia or correlate well with clinical outcomes after interventions like catheter ablation (CA).

Purpose of the Study:

  • To review the impact and prognostic value of atrial fibrillation burden.
  • To highlight challenges, including the lack of a standardized definition and consensus on its clinical use.
  • To explore the role of advanced monitoring strategies, including wearables and AI.

Main Methods:

  • Literature review summarizing current knowledge on AF burden.
  • Discussion of emerging evidence on AF burden's clinical relevance.
  • Exploration of future monitoring technologies.

Main Results:

  • AF burden, defined as the percentage of time in arrhythmia, shows promise in reflecting CA outcomes and predicting prognosis in certain patient groups.
  • Existing definitions are inconsistent, necessitating standardization.
  • Continuous monitoring strategies, potentially enhanced by wearables and AI, are crucial.

Conclusions:

  • AF burden may offer a more precise assessment of AF management than traditional metrics.
  • Standardization of AF burden definition and integration into clinical practice are essential.
  • Technological advancements in monitoring hold significant potential for improved AF management.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
396
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
212
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
319
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255